Suppr超能文献

托拉塞米显著减少噻嗪类药物引起的钾和镁流失,尽管存在超相加性利钠作用。

Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis.

作者信息

Knauf H, Mutschler E, Velazquez H, Giebisch G

机构信息

Department of Medicine 1, St. Bernward-Krankenhaus, Hildesheim 31134, Germany.

出版信息

Eur J Clin Pharmacol. 2009 May;65(5):465-72. doi: 10.1007/s00228-009-0626-7. Epub 2009 Feb 20.

Abstract

BACKGROUND

Resistance to high-dose loop diuretics can be overcome either by co-administration with thiazides or by treatment with medium-dose loop diuretics combined with thiazides. Combination therapy has been proven to be superior to high-dose loop diuretic monotherapy for cardiac and renal edema. However, such a strongly efficacious short-term regimen is often complicated by undesired effects, including circulatory collapse and electrolyte disturbances. The question of whether the loop diuretic/thiazide combinations are efficacious and safe when conventional doses are combined has not yet been answered.

METHODS

The effects of hydrochlorothiazide (HCT) and torasemide (TO) given alone on the excretion of Na+, Cl-, K+, Mg2+, and Ca2+ were compared with the effects of combined administration of the diuretics in 12 healthy volunteers.

RESULTS

The co-administration of HCT (25 mg) with TO (5 or 10 mg) strongly increased Na+ excretion. However, the combination significantly reduced K+ and Mg2+ excretion. The K+-sparing effect of the HCT/TO combination was shown to be due to a significant reduction in the HCT-induced increase in fractional K+ excretion by the loop diuretic. Total excretion of Ca2+ relative to Na+ excretion was less with the HCT/TO combination than with TO given alone.

CONCLUSION

The enhancement of desired NaCl excretion by the HCT/TO combination with significant reduction of undesired loss of K+ and Mg2+ meets clinical requirements but has to be validated in long-term clinical trials.

摘要

背景

高剂量袢利尿剂的耐药性可通过与噻嗪类药物联合使用或用中剂量袢利尿剂与噻嗪类药物联合治疗来克服。联合治疗已被证明在治疗心脏和肾性水肿方面优于高剂量袢利尿剂单一疗法。然而,这种疗效显著的短期治疗方案常常伴有不良影响,包括循环衰竭和电解质紊乱。当联合使用常规剂量时,袢利尿剂/噻嗪类药物组合是否有效且安全的问题尚未得到解答。

方法

将12名健康志愿者单独使用氢氯噻嗪(HCT)和托拉塞米(TO)对Na+、Cl-、K+、Mg2+和Ca2+排泄的影响与联合使用这两种利尿剂的影响进行比较。

结果

HCT(25毫克)与TO(5或10毫克)联合使用可显著增加Na+排泄。然而,这种组合显著减少了K+和Mg2+排泄。HCT/TO组合的保钾作用表明,这是由于袢利尿剂引起的HCT诱导的K+排泄分数增加显著降低。与单独使用TO相比,HCT/TO组合的Ca2+相对于Na+排泄的总排泄量更少。

结论

HCT/TO组合增强了所需的NaCl排泄,同时显著减少了K+和Mg2+的不必要损失,符合临床需求,但必须在长期临床试验中得到验证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验